Topiramate Tablet
Product Images NDC 76282-280

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 76282-280). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Topiramate Structure (Topiramate Structure)

Chemical structure of Topiramate, showing its molecular arrangement with multiple oxygen atoms, methyl groups, and sulfonamide functional group.*

FDA Label Image

Topiramate-fig1 (Topiramate Fig1)

A line chart showing cumulative rates for time to first seizure over a period of 500 days in patients taking Topiramate 50 mg/day and 400 mg/day. The graph compares seizure occurrence between the two dosage groups, indicating statistical significance with a p-value of 0.0002.*

FDA Label Image

Topiramate Figure 2 (Topiramate Figure 2)

A bar graph comparing the change from baseline in double-blind phase 3 monthly average migraine pretreatment rates across placebo and Topiramate at 50 mg/day, 100 mg/day, and 200 mg/day doses. Data from two studies (Study 10 and Study 11) are shown, with black bars for Study 10 and patterned bars for Study 11. The graph includes statistical significance markers for differences at p<0.01 and p<0.001 levels.*

FDA Label Image

Topiramate-fig3-inv (Topiramate Fig3 Inv)

Label for Topiramate Tablets, USP 25 mg oral tablets by Exelan Pharmaceuticals Inc. The label indicates a quantity of 1000 tablets with NDC 76282-278-10. It includes storage instructions, manufacturer and distributor information, and a barcode.*

FDA Label Image

Topiramate-fig4-inv (Topiramate Fig4 Inv)

Topiramate Tablets, USP 50 mg oral tablets label from Exelan Pharmaceuticals Inc. The label includes the NDC 76282-279-10, a 1000-tablet count, pharmacist dispensing instructions, storage temperature, and manufacturer information for InvaGen Pharmaceuticals and Exelan Pharmaceuticals. The label also shows a barcode and a QR code.*

FDA Label Image

Topiramate-fig5-inv (Topiramate Fig5 Inv)

Label for Topiramate Tablets, USP 100 mg oral tablets by Exelan Pharmaceuticals, Inc. The label indicates the product is Rx only and the package contains 1000 tablets. The label displays storage instructions (20° to 25°C) and manufacturer details, including InvaGen Pharmaceuticals, Inc. as manufacturer and Exelan Pharmaceuticals, Inc. as labeler. The NDC number 76282-280-10 is shown.*

FDA Label Image

Topiramate-fig6-inv (Topiramate Fig6 Inv)

Topiramate Tablets, USP 200 mg oral tablets label by Exelan Pharmaceuticals, Inc. The label includes the NDC 76282-281-10, states the quantity as 1000 tablets, and notes storage at 20 to 25°C. It indicates manufacturer information: InvaGen Pharmaceuticals, a Cipla Ltd. subsidiary, and manufacturing for Exelan Pharmaceuticals in Boca Raton, FL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.